FTC v. Actavis, Inc.: Supreme Court Rules That Reverse Patent Settlements May Violate Antitrust Laws* On June 17, 2013, in FTC v. Actavis, Inc., the Supreme Court ruled that "reverse patent settlements" may violate the Sherman Act even though the anticompetitive effects of the settlement fall within the potential scope of the patent. The Court's 5-to-3 ruling resolved a circuit split between the Third Circuit, which had held reverse patent settlements presumptively unlawful under the "quick look" approach, and the Eleventh Circuit, which had held reverse patent settlements immune from antitrust scrutiny so long as the anticompetitive effects of the settlement was within the potential scope of the patent. Although the Supreme Court rejected the Eleventh Circuit's approach, the Court
Partager sur
|
|
The US Supreme Court rules that reverse patent settlements may violate antitrust law (Actavis)
L'accès à cet article est réservé aux abonnés
Déjà abonné ? Identifiez-vous
L’accès à cet article est réservé aux abonnés.
Lire gratuitement un article
Vous pouvez lire cet article gratuitement en vous inscrivant.
